mPGES1-IN-3
mPGES1-IN-3 is a selective, orally active mPGES-1 inhibitor with an IC50 of 8.0 nM for h-mPGES-1 and an IC50 of 10.79 nM for guinea pig mPGES1. mPGES1-IN-3 blocks the conversion of PGH2 (HY-136500) to PGE2 (HY-101952). mPGES1-IN-3 exhibits dose-dependent inhibition of LPS-induced thermal hyperalgesia. mPGES1-IN-3 can be used for research on rheumatoid arthritis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 1469976-70-2
- 分子式: C24H16ClF5N4O3
- 分子量:538.85
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
IC50: 8 nM (mPGES-1)[1]
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
16.24 nM
|
Inhibition of PGE2 production in human A549 cells in the presence of 2% FBS.
Inhibition of PGE2 production in human A549 cells in the presence of 2% FBS.
|
27865703 |
体外実験
mPGES1-IN-3 (Compound 17d) (10 μM; 60 min) exhibits favorable in vitro ADME properties, including good HWB potency, high metabolic stability across species, minimal CYP inhibition, and high plasma protein binding[1].
mPGES1-IN-3 (10 μM) exhibits much higher selectivity for mPGES-1 over other prostaglandin synthases and COX enzymes, and has a favorable hERG and off-target safety profile[1].
mPGES1-IN-3 is a potent inhibitor of guinea pig mPGES-1 and h-mPGES-1, but shows no inhibitory effect on rat or mouse mPGES-1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
| Species | Dose | Route | T1/2 | CL | Vz | Cmax | AUC | Tmax | Bioavailability |
|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 1 mg/kg | i.v. | 6.2 h | 18.0 mL/min/kg | 10.24 L/kg | / | / | / | / |
| Rat[1] | 10 mg/kg | p.o. | / | / | / | 29.0 ng/mL | 149 ng·h/mL | 4 h | 1.5 % |
| Rat[1] | 10 mg/kg | p.o. | / | / | / | 163 ng/mL | 2259 ng·h/mL | 4 h | 23 % |
| Rat[1] | 30 mg/kg | p.o. | / | / | / | 598 ng/mL | 8403 ng·h/mL | 8 h | 29 % |
| Rat[1] | 100 mg/kg | p.o. | / | / | / | 2035 ng/mL | 23,114 ng·h/mL | 2 h | 24 % |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Guinea pig hyperalgesia pain model[1]
-
Dosage:10, 30, 60,100 mg/kg
-
Administration:p.o.
-
Result:Significantly inhibited
hyperalgesic response in a dose-dependent manner with maxi-
mum inhibition of 73% at 100 mg/kg.
Inhibited <50% of hyperalgesic response in comparison with Diclofenac (10 and 30 mg/kg)
化学情報
-
CAS 番号 1469976-70-2
-
分子量 538.85
-
分子式 C24H16ClF5N4O3
-
SMILES
O=C(NC1=CC(F)=CC(C(F)(F)F)=C1)C2=C(OCCO3)C3=C(N(C)C(NC4=C(Cl)C=CC=C4F)=N5)C5=C2
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)